Literature DB >> 23525959

Keratouveitis caused by Euphorbia trigona sap.

Yasin Cinar1, Fatih Mehmet Turkcu, Abdullah Kursat Cingu, Harun Yuksel, Muhammed Sahin, Alparslan Sahin.   

Abstract

We present a case of a 40-year-old female with severe keratouveitis secondary to Euphorbia trigona plant sap. The patient dropped sap into both eyes to relieve itching and developed Euphorbia keratouveitis. Visual acuity was finger counting at 1 m in both eyes on presentation. On examination, eyelid edema, ciliary injection, corneal edema with Descemet membrane folds and exudate in the anterior chamber were seen bilaterally. With supportive treatment all signs and symptoms were relieved. Exposure to Euphorbia sap should be treated immediately to prevent sequelae like corneal scarring.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525959     DOI: 10.1007/s10792-013-9760-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  5 in total

1.  Boston keratoprosthesis restoring vision in an unusual case of end-stage limbal stem cell deficiency following exposure to Euphorbia latex.

Authors:  Jayanta Dutta; Somnath Mukhopadhyay; Himadri Datta; Swarnali Sen
Journal:  Int Ophthalmol       Date:  2012-01-21       Impact factor: 2.031

2.  Euphorbia lactea sap keratouveitis: case report and review of the literature.

Authors:  Rohan Merani; Tarinee Sa-Ngiampornpanit; Yves Kerdraon; Frank Billson; Kathy A McClellan
Journal:  Cornea       Date:  2007-07       Impact factor: 2.651

3.  Plant dermatitis. Irritant plants in the spurge family (Euphorbiaceae).

Authors:  G L Webster
Journal:  Clin Dermatol       Date:  1986 Apr-Jun       Impact factor: 3.541

4.  Euphorbia sap keratopathy: four cases and a possible pathogenic mechanism.

Authors:  I U Scott; C L Karp
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

5.  Keratouveitis caused by Euphorbia plant sap.

Authors:  Samar K Basak; Partho K Bakshi; Sabitabrata Basu; Soham Basak
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.